Sophia Kaestle

Dr. Sophia Kaestle


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
MKMelanie Kimm
Melanie Kimm
CKChristopher Klenk
Christopher Klenk
MAMarianna Alunni-Fabbroni
Marianna Alunni-Fabbroni
SKSophia Kaestle
Sophia Kaestle
MSMatthias Stechele
Matthias Stechele
Moritz WildgruberMoritz Wildgruber
Moritz Wildgruber
Tumor-associated macrophages (TAMs) represent the largest group of leukocytes within the tumor microenvironment (TME) of solid tumors and orchestrate the composition of anti- as well as pro-tumorigenic factors. This makes TAMs an excellent target for novel cancer therapies. The plasticity of TAMs resulting in varying membrane receptors and expression of intracellular proteins allow the specific characterization of different subsets of TAMs. Those markers similarly allow tracking of TAMs by different means of molecular imaging. This review aims to provides an overview of the origin of tumor-associated macrophages, their polarization in different subtypes, and how characteristic markers of the subtypes can be used as targets for molecular imaging and theranostic approaches.

28 December 2020 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
JRJohannes Rueckel
Johannes Rueckel
NFNicola Fink
Nicola Fink
SKSophia Kaestle
Sophia Kaestle
ASAnna Theresa Stüber
Anna Theresa Stüber
VSVincent Schwarze
Vincent Schwarze
BSBastian Sabel
Bastian Sabel
(1) Background: Time-consuming SARS-CoV-2 RT-PCR suffers from limited sensitivity in early infection stages whereas fast available chest CT can already raise COVID-19 suspicion. Nevertheless, radiologists’ performance to differentiate COVID-19, especially from influenza pneumonia, is not sufficiently characterized. (2) Methods: A total of 201 pneumonia CTs were identified and divided into subgroups based on RT-PCR: 78 COVID-19 CTs, 65 influenza CTs and 62 Non-COVID-19-Non-influenza (NCNI) CTs. Three radiology experts (blinded from RT-PCR results) raised pathogen-specific suspicion (separately for COVID-19, influenza, bacterial pneumonia and fungal pneumonia) according to the following reading scores: 0—not typical/1—possible/2—highly suspected. Diagnostic performances were calculated with RT-PCR as a reference standard. Dependencies of radiologists’ pathogen suspicion scores were characterized by Pearson’s Chi2 Test for Independence. (3) Results: Depending on whether the intermediate reading score 1 was considered as positive or negative, radiologists correctly classified 83–85% (vs. NCNI)/79–82% (vs. influenza) of COVID-19 cases (sensitivity up to 94%). Contrarily, radiologists correctly classified only 52–56% (vs. NCNI)/50–60% (vs. COVID-19) of influenza cases. The COVID-19 scoring was more specific than the influenza scoring compared with suspected bacterial or fungal infection. (4) Conclusions: High-accuracy COVID-19 detection by CT might expedite patient management even during the upcoming influenza season.